Senores Pharmaceuticals Limited (SPL) has officially inaugurated and commenced operations its state-of-the-art Active Pharmaceutical Ingredient (API) manufacturing facility in Rajpur, Kadi, Mehsana, Gujarat. Spanning approximately 230,000 sq. ft., this new plant boasts an impressive installed capacity of ~100 metric tons per annum, strengthening SPL’s position in the pharmaceutical industry.
This greenfield project marks Senores’ second API manufacturing facility, significantly expanding its production capabilities. The plant is designed to adhere to global quality standards, ensuring the delivery of high-purity APIs for the pharmaceutical sector.
Speaking on the occasion, Swapnil Shah, Managing Director of Senores Pharmaceuticals Limited, expressed his enthusiasm “We are delighted to commence operations at our greenfield state-of-the-art API facility atMehsana. Commissioning of this API facility will help Senores broaden its offerings andstrengthen its competitiveness in the Regulated Markets, especially in the CDMO/CMObusiness.”
